For: | Thota PN, Kistangari G, Esnakula AK, Gonzalo DH, Liu XL. Clinical significance and management of Barrett’s esophagus with epithelial changes indefinite for dysplasia. World J Gastrointest Pharmacol Ther 2016; 7(3): 406-411 [PMID: 27602241 DOI: 10.4292/wjgpt.v7.i3.406] |
---|---|
URL: | https://www.wjgnet.com/2150-5349/full/v7/i3/406.htm |
Number | Citing Articles |
1 |
Xiuxu Chen, Bella Lingjia Liu, Noam Harpaz, Hongfa Zhu, Alexandros D. Polydorides, Qingqing Liu. Aberrant p53 expression is associated with neoplastic progression in Barrett oesophagus diagnosed as indefinite for dysplasia. Histopathology 2023; 82(3): 454 doi: 10.1111/his.14828
|
2 |
Christopher Paiji, Alireza Sedarat. Endoscopic Management of Esophageal Cancer. Cancers 2022; 14(15): 3583 doi: 10.3390/cancers14153583
|
3 |
Richard Phillips, Wladyslaw Januszewicz, Nastazja D. Pilonis, Maria O'Donovan, Tarek Sawas, David A. Katzka, Rebecca C. Fitzgerald, Massimiliano di Pietro. The risk of neoplasia in patients with Barrett's esophagus indefinite for dysplasia: a multicenter cohort study. Gastrointestinal Endoscopy 2021; 94(2): 263 doi: 10.1016/j.gie.2021.01.042
|
4 |
Daniela Pereira, Bence Kővári, Ian Brown, Paula Chaves, Won‐Tak Choi, Till Clauditz, Masoumeh Ghayouri, Kun Jiang, Gregory C Miller, Yukihiro Nakanishi, Kyoung M Kim, Baek H Kim, Marian P Kumarasinghe, Ryoji Kushima, Tetsuo Ushiku, Masato Yozu, Amitabh Srivastava, John R Goldblum, Rish K Pai, Gregory Y Lauwers. Non‐conventional dysplasias of the tubular gut: a review and illustration of their histomorphological spectrum. Histopathology 2021; 78(5): 658 doi: 10.1111/his.14294
|
5 |
Shiwei HAN, Donald E. LOW. LAPAROSCOPIC ANTIREFLUX SURGERY: ARE OLD QUESTIONS ANSWERED? SHOULD IT BE USED CONJOINED WITH ENDOSCOPIC THERAPY FOR BARRETT’S ESOPHAGUS?. ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 2022; 35 doi: 10.1590/0102-672020210002e1664
|